Concepedia

Transduction of Primary Lymphocytes with Epstein-Barr Virus (EBV) Latent Membrane Protein-Specific T-Cell Receptor Induces Lysis of Virus-Infected Cells: A Novel Strategy for the Treatment of Hodgkin's Disease and Nasopharyngeal Carcinoma

Lisa A. Jurgens, Rajiv Khanna, James J. Weber, Rimas J. Orentas

Journal of Clinical Immunology · 2006 · 30 citations · 26 references

DOIFull text

Open access

Concepts

References

26

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

Cliona M. Rooney · The Lancet · 1995 · 1.2K citations

, , +8

Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation

Esperanza B. Papadopoulos, Marc Ladanyi, David Emanuel et al. · New England Journal of Medicine · 1994 · 1.1K citations · Full text

Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes

Helen E. Heslop, Catherine Y. Ng, Congfen Li et al. · Nature Medicine · 1996 · 831 citations

, , +10

Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1

Jelena Levitskaya, Michael Coram, Victor Levitsky et al. · Nature · 1995 · 821 citations

, , +6

Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts

Lucy Brooks, Q. Y. Yao, Alan B. Rickinson et al. · Journal of Virology · 1992 · 485 citations · Full text

, , +15